Michael Kreuter

2001–2025 年に発表

172
論文数
19,631
被引用数
71
h 指数
160
i10 指数

被引用数

Michael Kreuter の年別被引用数1993 年: 被引用 1 件1998 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 16 件2003 年: 被引用 13 件2004 年: 被引用 7 件2005 年: 被引用 21 件2006 年: 被引用 17 件2007 年: 被引用 17 件2008 年: 被引用 17 件2009 年: 被引用 11 件2010 年: 被引用 8 件2011 年: 被引用 12 件2012 年: 被引用 11 件2013 年: 被引用 4 件2014 年: 被引用 11 件2015 年: 被引用 16 件2016 年: 被引用 39 件2017 年: 被引用 52 件2018 年: 被引用 80 件2019 年: 被引用 342 件2020 年: 被引用 925 件2021 年: 被引用 1,087 件2022 年: 被引用 944 件2023 年: 被引用 817 件2024 年: 被引用 1,467 件2025 年: 被引用 647 件2026 年: 被引用 21 件1994〜1997 年は被引用が無いため表示していません1999〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,343 件、この内訳の 17.9%中国: 引用元論文 816 件、この内訳の 10.8%イギリス: 引用元論文 568 件、この内訳の 7.5%ドイツ: 引用元論文 563 件、この内訳の 7.5%イタリア: 引用元論文 507 件、この内訳の 6.7%フランス: 引用元論文 348 件、この内訳の 4.6%日本: 引用元論文 317 件、この内訳の 4.2%カナダ: 引用元論文 286 件、この内訳の 3.8%オーストラリア: 引用元論文 237 件、この内訳の 3.2%オランダ: 引用元論文 223 件、この内訳の 3%スペイン: 引用元論文 207 件、この内訳の 2.8%スイス: 引用元論文 169 件、この内訳の 2.2%
0%17.9%その他 25.8%

分野

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Neuroscience2.2%
  • Immunology and Microbiology1.9%
  • Engineering0.6%
  • Computer Science0.6%
  • その他2.1%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis19.5%
  • Systemic Sclerosis and Related Diseases5.2%
  • COVID-19 Clinical Research Studies3.9%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.9%
  • Sarcoidosis and Beryllium Toxicity Research3.7%
  • SARS-CoV-2 and COVID-19 Research3.3%
  • その他60.5%

共著者

全論文

検索で開く
  1. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Ho, Julie Morisset, Amy L. Olson, Anna Podolanczuk, Venerino Poletti, Moisés Selman, Thomas Ewing, Stephen Jones, Shandra L. Knight, Marya Ghazipura, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 2,618

  2. Global incidence and prevalence of idiopathic pulmonary fibrosis

    著者: , , , , , , , - Respiratory Research 2021 被引用: 601

  3. Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa A. Maier, Carlos Matiz, Ferrán Morell, Andrew G. Nicholson, Setu Patolia, Carlos A.C. Pereira, Elisabetta Renzoni, Margaret L. Salisbury, Moisés Selman, Simon Walsh, Wim Wuyts, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 1,012

  4. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Klaus F. Rabe, Francesco Bonella, R. Bonnet, Christian Grohé, Matthias Held, Heinrike Wilkens, Peter Hammerl, Dirk Koschel, Stefan Blaas, Hubert Wirtz, Joachim H. Ficker, Wolfgang Neumeister, N Schönfeld, Martin Claussen, Nikolaus Kneidinger, Marion Frankenberger, Simone Hummler, Nicolas Kahn, Silke Tello, Julia Freise, Tobias Welte, Petra Neuser, Andreas Günther, Carmen Schade‐Brittinger, Behnaz Aminossadati, Christian Nasemann, Soraya Yahiaoui, Christoph Dupuy Backofen, Maik Hahmann, Michael Wittenberg, Fotis Drakopanagiotakis, Daniel von der Beck, Stefanie Ghofrani, S Heinemann, Ekaterina Krauss, Hella Rethorn, Andrea Koch, Gabriela Leuschner, Sandhya Matthes, Claus Neurohr, Tobias Veit, Katrin Milger, Felix Herth, Julia Benstz, Simone Hummler, Thomas Bahmer, Heike Biller, Benjamin Waschki, Rosa-Marie Apel, Ulrich Costabel, Eva Börner, Thomas Wessendorf, M. Arnrich, Lacramioara Ilie, Alexandra Wald, Hans‐Jürgen Seyfarth, Christian Reinhardt, Atif Cinar, Markus Vogler, Siegfried Matthias Huhn, Jaqueline Richter, U Neff, Torsten Blum, Silvan Vesenbeckh, Christian Boch, Hannes Semper, Andreas Wilke, Michael Pfeifer, Annette Schweda, Angelika Krill ほか 7 名 - The Lancet Respiratory Medicine 2021 被引用: 516

  5. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , - The Lancet Respiratory Medicine 2019 被引用: 630

  6. Pulmonary fibrosis: from pathogenesis to clinical decision-making

    著者: , , , , - Trends in Molecular Medicine 2023 被引用: 213

  7. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Blaas, Benjamin Bondue, Francesco Bonella, E. James Britt, Ketan Buch, John R. Burk, Hourong Cai, André M. Cantin, D.M. Castillo Villegas, Agustina Díaz Cazaux, Stefania Cerri, Said Chaaban, Nazia Chaudhuri, Vincent Cottin, Bruno Crestani, Gerard J. Criner, Caroline Dahlqvist, Sonye K. Danoff, J. Dematte D'Amico, Daniel F. Dilling, Paulo Eduardo Elias, Neil Ettinger, Jeremy Falk, Evans R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, Alex H. Gifford, Marilyn K. Glassberg, Craig S. Glazer, Jeffrey A. Golden, Luis Gómez Carrera, Julien Guiot, Robert W. Hallowell, Hiroki Hayashi, J. Hetzel, Nik Hirani, L. Homik, Benjamin Hope-Gill, David Hotchkin, Kazuya Ichikado, M. M. Ilkovich, Yoshikazu Inoue, Shinyu Izumi, Ewa Jassem, Leonie Jones, S. Jouneau, Robert J. Kaner, Jian Kang, Tsuyoshi Kawamura, Romain Kessler, Y. Kim, Kazuma Kishi, Hideya Kitamura, Martin Kolb, Yasuhiro Kondoh, Chiyoko Kono, Dirk Koschel, Michael Kreuter, Tejaswini Kulkarni, Jan Kuś, F. Lebargy, Antonio León Jiménez, Qun Luo, Yolanda Mageto, Toby M. Maher, Shigeki Makino, S. Marchand‐Adam, Charles‐Hugo Marquette, Raquel Martínez, Martin Ulises Gutierrez Martinez ほか 68 名 - The Lancet Respiratory Medicine 2020 被引用: 559

  8. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

    著者: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 346

  9. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamera J. Corte, Ian Glaspole, Nicole Goh, Mark Holmes, M.A. Malouf, Francis Thien, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Antoine Froidure, Hans Slabbynck, Wim Wuyts, Claudia Cartagena Salinas, Rosa Feijoó Seoane, Victor D. Martínez, Roxana Maturana, Juana Pavie Gallegos, Andrés Rosenblüt, Rafael Silva, Alvaro Undurraga Pereira, Martina Doubková, Norbert Pauk, Martina Plačková, Martina Šterclová, Elisabeth Bendstrup, Saher Burhan Shaker, Ingrid Louise Titlestad, Stephan Budweiser, Christian Grohé, Dirk Koschel, Michael Kreuter, Antje Prasse, Michael Weber, Hubert Wirtz, Κατερίνα Αντωνίου, Zoe Daniil, Mina Gaga, Despoina Papakosta, Shinyu Izumi, Masaki Okamoto, Alfredo Guerreros Benavides, Carlos Barrera, Alejandro Manuel Peña Villalobos, Aranzazu Campo Ezquibela, José M. Cifrián, Estrella Fernández Fabrellas, Virginia Leiro, María Molina‐Molina, Asunción Nieto Barbero, Jacobo Sellarés, Claudia Valenzuela, Shih-Lung Cheng, Ping‐Hung Kuo, Kang‐Yun Lee, Chau‐Chyun Sheu, Hakan Günen, Nesrin Moğulkoç, Sibel Naycı, Huzaifa Adamali, Stephen Bianchi, Nazia Chaudhuri, Michael Gibbons, Simon P. Hart, Philip L. Molyneaux, Helen Parfrey, Gauri Saini, Lisa Spencer, Sarah Wiscombe, Danielle Antin‐Ozerkis, Rebecca Bascom ほか 152 名 - JAMA 2023 被引用: 127

  10. SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

    著者: , , , , , , , , , , , , , - The EMBO Journal 2020 被引用: 1,017

  11. The therapy of idiopathic pulmonary fibrosis: what is next?

    著者: , , , , , - European Respiratory Review 2019 被引用: 285

  12. Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study

    著者: , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2021 被引用: 173

  13. Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial

    著者: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 被引用: 297

  14. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management

    著者: , , , , - Respiratory Research 2021 被引用: 216

  15. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

    著者: , , , , , , , , , , - Current Medical Research and Opinion 2019 被引用: 258

  16. Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 198

  17. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , - JAMA 2018 被引用: 225

  18. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ewa Więsik–Szewczyk, Oliver Distler - The Lancet Rheumatology 2020 被引用: 300

  19. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON

    著者: , , , , , , , , , , - The Lancet Respiratory Medicine 2018 被引用: 239

  20. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2024 被引用: 65

  21. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 被引用: 189

  22. Home monitoring in interstitial lung diseases

    著者: , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 被引用: 99

  23. Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , - PLoS ONE 2016 被引用: 352

  24. Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Respirology 2022 被引用: 73